Zobrazeno 1 - 10
of 982
pro vyhledávání: '"Sensintaffar, J"'
Autor:
Zheng, Shengfeng1,2,3,4 (AUTHOR), Hong, Zhe1,2,3 (AUTHOR) hz_urology@shca.org.cn, Tan, Yao1,2,5 (AUTHOR), Wang, Yue1,2,3 (AUTHOR), Li, Junhong1,2,3 (AUTHOR), Zhang, Zihao1,2,3 (AUTHOR), Feng, Tao1,2,3 (AUTHOR), Hong, Zongyuan6 (AUTHOR) zyhong@wnmc.edu.cn, Lin, Guowen1,2,3 (AUTHOR) guowenlin@urocancer.org, Ye, Dingwei1,2,3 (AUTHOR) dwyeli@163.com
Publikováno v:
Cell Communication & Signaling. 10/24/2024, Vol. 22 Issue 1, p1-18. 18p.
Publikováno v:
Scopus-Elsevier
CTL responses are governed by intracellular Ag processing, affinity of peptides for MHC class I molecules, and the T cell repertoire. In this report we demonstrate that a class I Dd-restricted 10-mer CTL epitope within the gp160 envelope glycoprotein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6336ab81f86c212e20db60562e8a99af
https://doi.org/10.4049/jimmunol.152.12.5603
https://doi.org/10.4049/jimmunol.152.12.5603
Autor:
Hoogstra, Shawn J.1 (AUTHOR) shawn.hoogstra@agr.gc.ca, Hendricks, Kyle N.1,2 (AUTHOR) justin.renaud@agr.gc.ca, McMullin, David R.3 (AUTHOR) davidmcmullin@cunet.carleton.ca, Renaud, Justin B.1 (AUTHOR), Bora, Juhi1 (AUTHOR), Sumarah, Mark W.1 (AUTHOR) mark.sumarah@agr.gc.ca, Garnham, Christopher P.1 (AUTHOR) mark.sumarah@agr.gc.ca
Publikováno v:
Toxins. Sep2024, Vol. 16 Issue 9, p404. 16p.
Autor:
Choi, Kyoung-Min1 (AUTHOR), Kim, Sung-Jin1 (AUTHOR), Ji, Mi-Jung2 (AUTHOR), Kim, Eunjung3 (AUTHOR), Kim, Jae-Sung4 (AUTHOR), Park, Hyun‑Mee2 (AUTHOR), Kim, Jae-Young1 (AUTHOR) jaeyoungkim@cnu.ac.kr
Publikováno v:
Cell Communication & Signaling. 8/14/2024, Vol. 22 Issue 1, p1-15. 15p.
Autor:
Govek SP; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States. Electronic address: sgovek@san.rr.com., Bonnefous C; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Julien JD; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Nagasawa JY; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Kahraman M; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Lai AG; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Douglas KL; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Aparicio AM; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Darimont BD; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Grillot KL; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Joseph JD; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Kaufman JA; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Lee KJ; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Lu N; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Moon MJ; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Prudente RY; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Sensintaffar J; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Rix PJ; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Hager JH; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States., Smith ND; Seragon Pharmaceuticals, Inc., 12780 El Camino Real, Suite 302, San Diego, CA 92130, United States.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Feb 01; Vol. 29 (3), pp. 367-372. Date of Electronic Publication: 2018 Dec 19.
Autor:
Joseph JD, Darimont B, Zhou W, Arrazate A, Young A, Ingalla E, Walter K, Blake RA, Nonomiya J, Guan Z, Kategaya L, Govek SP, Lai AG, Kahraman M, Brigham D, Sensintaffar J, Lu N, Shao G, Qian J, Grillot K, Moon M, Prudente R, Bischoff E, Lee KJ, Bonnefous C, Douglas KL, Julien JD, Nagasawa JY, Aparicio A, Kaufman J, Haley B, Giltnane JM, Wertz IE, Lackner MR, Nannini MA, Sampath D, Schwarz L, Manning HC, Tantawy MN, Arteaga CL, Heyman RA, Rix PJ, Friedman L, Smith ND, Metcalfe C, Hager JH
Publikováno v:
ELife [Elife] 2019 Jan 07; Vol. 8. Date of Electronic Publication: 2019 Jan 07.
Autor:
Kahraman M; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Govek SP; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Nagasawa JY; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Lai A; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Bonnefous C; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Douglas K; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Sensintaffar J; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Liu N; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Lee K; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Aparicio A; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Kaufman J; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Qian J; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Shao G; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Prudente R; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Joseph JD; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Darimont B; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Brigham D; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Heyman R; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Rix PJ; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Hager JH; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States., Smith ND; Department of Chemistry, Department of Biology, and Department of Drug Safety and Disposition, Seragon Pharmaceuticals, 12780 El Camino Real, Suite 302, San Diego, California 92130, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2018 Dec 06; Vol. 10 (1), pp. 50-55. Date of Electronic Publication: 2018 Dec 06 (Print Publication: 2019).
Autor:
Ramsey HE; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Fischer MA; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Lee T; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt Institute for Chemical Biology, Vanderbilt University, Nashville, Tennessee., Gorska AE; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Arrate MP; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Fuller L; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Boyd KL; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee., Strickland SA; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Sensintaffar J; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee., Hogdal LJ; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee., Ayers GD; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Olejniczak ET; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt Institute for Chemical Biology, Vanderbilt University, Nashville, Tennessee., Fesik SW; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt Institute for Chemical Biology, Vanderbilt University, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Savona MR; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. michael.savona@vanderbilt.edu.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Publikováno v:
Cancer discovery [Cancer Discov] 2018 Dec; Vol. 8 (12), pp. 1566-1581. Date of Electronic Publication: 2018 Sep 05.
Autor:
Nagasawa J, Govek S, Kahraman M, Lai A, Bonnefous C, Douglas K, Sensintaffar J, Lu N, Lee K, Aparicio A, Kaufman J, Qian J, Shao G, Prudente R, Joseph JD, Darimont B, Brigham D, Maheu K, Heyman R, Rix PJ, Hager JH, Smith ND
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2018 Sep 13; Vol. 61 (17), pp. 7917-7928. Date of Electronic Publication: 2018 Sep 04.
Autor:
Bruserud, Øystein1,2 (AUTHOR) mariahv@ugr.es, Selheim, Frode3 (AUTHOR) frode.selheim@uib.no, Hernandez-Valladares, Maria1,4,5 (AUTHOR) hakon.reikvam@uib.no, Reikvam, Håkon1,2 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6356. 41p.